Royal Canin Goes Fresh for the First Time and Keeps It Behind the Vet Counter

Royal Canin launched its first fresh, fully cooked therapeutic diet portfolio on July 14: three prescription formulas sold exclusively through veterinary practices and their online pharmacy partners. Mars' clinical nutrition flagship has effectively conceded that fresh is a format veterinarians now need to offer, and it is using channel exclusivity to make sure the version they reach for carries a Royal Canin label.

Three prescription formulas bring the fresh format into Royal Canin's vet-exclusive lineup

Royal Canin Fresh Veterinary Diets arrives in the U.S. this month with three formulations, each mapped to a common clinical workflow. Gastrointestinal Low Fat is the brand's lowest-fat fresh formula, built for dogs that need fat-restricted nutrition. Selected Protein Pork is a single-animal-protein diet for dogs managing food sensitivities. Appetite Stimulation is a nutrient-dense formula for dogs eating poorly or recovering from illness.

Distribution is the defining choice: the line is available only through veterinary practices and veterinary online pharmacy partners, not retail.

"Nutrition is one of the most powerful tools we have to support dogs managing chronic illnesses," said Dr. Brent Mayabb, Royal Canin's global chief medical officer. Jennifer Cullen, who runs the U.S. veterinary business unit, framed the line as giving veterinary teams "new therapeutic options" in a fresh, fully cooked format.

Royal Canin, founded in 1968 by French veterinarian Jean Cathary, is a multibillion-dollar brand inside Mars and one of the most entrenched names in therapeutic pet nutrition. This is the first time it has put that clinical franchise into fresh food.

Two science incumbents moved into fresh within two weeks, and their channel choices are the real story

Fresh dog food was built outside the clinic. Direct-to-consumer subscription brands taught a generation of premium owners to expect refrigerated, gently cooked meals delivered to the door, and JustFoodForDogs spent years pushing the format toward medicine with fresh veterinary-support diets and a dedicated vet channel.

What changed this month is that both big-science incumbents committed at once. Hill's announced its Science Diet Single Protein refrigerated rolls on June 30, headed for pet specialty retail. Royal Canin followed two weeks later and chose the opposite door: prescription-only, vet channel only.

That split is deliberate, and it maps to what each company is defending. Hill's is protecting shelf presence where fresh fridges are already spreading. Royal Canin is protecting the exam-room recommendation, the highest-trust moment in pet food. Making its first fresh products therapeutic rather than wellness diets ties them to medical workflows: a diagnosis, a prescription, compliance checks, recheck visits. That preserves premium pricing, keeps the products out of side-by-side comparison shopping, and gives practices a reason to hold the relationship rather than lose it to a DTC subscription.

The operational implications run downstream. Fresh therapeutic food at Royal Canin scale means refrigeration, shorter shelf lives, and perishable inventory management landing on practices that have never carried it, and a cold-chain problem for the distributors and online pharmacy partners that will likely end up moving most of the volume. Capacity is the other constraint: fresh, fully cooked production is exactly the manufacturing bottleneck the DTC players spent a decade and hundreds of millions building around.

For the DTC fresh brands, the moat question just got sharper. When the veterinarian can prescribe a fresh diet from the clinic's default therapeutic brand, "fresh" by itself stops being a differentiator, and the fight shifts to palatability, breadth, and the direct relationship with the owner.

Cold-chain execution and formula breadth will decide whether fresh becomes a standard veterinary format

Three formulas is a toehold, not a portfolio. The signal to watch is whether Royal Canin extends fresh into the volume drivers of therapeutic nutrition, such as renal and dermatologic diets. Expansion there would say the company sees fresh as a core clinical format rather than a defensive flanker.

Watch the logistics model just as closely. If most volume routes through veterinary online pharmacy partners shipping direct to owners, practices can prescribe without stocking fridges, and the line scales faster than clinic infrastructure would suggest. If in-clinic sales matter, refrigeration becomes a real capital and workflow question for practice managers.

Purina, the third leg of the science-diet triopoly, has not shown its fresh hand, and its response will indicate whether this becomes a category-wide format war. And keep an eye on how the DTC players answer: clinical studies, veterinary advisory boards, or acquisition conversations with strategics would all be logical countermoves.

If fresh therapeutic nutrition works at Royal Canin scale, the format completes its journey from disruptor wedge to standard of care. At that point, the scarce assets in the category are cooked-fresh manufacturing capacity and cold-chain distribution into the veterinary channel, and owning either becomes very interesting.

Source: Royal Canin announcement via PR Newswire